Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl-L-Leucine in Niemann-Pick type C Disease
DRKS00016567Phase 2Recruiting
- Sponsor
- IntraBio
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, open-label, single-arm trial of levacetylleucine in Niemann-Pick disease type C (NPC), sponsored by IntraBio. Started Jun 2019; status: recruiting.
02
Drugs
levacetylleucine
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on DRKS00016567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00016567.